PJ

Pramila Jain

Active Director Director DIN 07160451
DIN 07160451 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Pramila Jain

Data last updated:

Pramila Jain is a Director at Kunal Pharma Distributors Private Limited (since 2015). The company operates in Pharma. Kunal Pharma Distributors Private Limited reported revenue of ₹203 Cr (FY 2025).

DIN 07160451
Primary Designation Director
Industry Pharma
First Appointment 09 Jul 2015
Oldest Company Age 37 yrs
Largest company Kunal Pharma Distributors Private Limited · ₹203 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jul 20151989₹203 Cr (FY 2025)Active

Board colleagues of Pramila Jain

Directorship timeline

Open interactive timeline →
Kunal Pharma Distributors Private Limited
Premium access

Shareholding and investment profile for Pramila Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pramila Jain

Pramila Jain currently holds 1 directorship: Kunal Pharma Distributors Private Limited (Director, since 09 Jul 2015, revenue ₹203 Cr (FY 2025)).

Pramila Jain was first appointed on 09 Jul 2015 as Director at Kunal Pharma Distributors Private Limited.

The current boards of Pramila Jain's companies include Kunal Jain (Kunal Pharma Distributors Private Limited), Prahlad Kumar Jain (Kunal Pharma Distributors Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available